This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.  
  • Delicious




EC Launches Investor Compensation Schemes Directive Review

by Ulrika Lomas, Tax-News.com, Brussels

11 February 2009

The European Commission has launched a call for evidence on the review of the application of the Investor Compensation Schemes Directive (Directive 1997/9/EC).

The Directive aims to protect investors against the risk of losses in the event of an investment firm's inability to repay money or return assets held on behalf of their clients.

The Commission now wishes to gather information about the application of the Directive. All interested stakeholders, in particular businesses, investors and consumers, and public authorities are invited to participate. This call for evidence is also in line with parallel initiatives concerning the Deposit Guarantee Schemes Directive and insurance guarantee schemes. The closing date reply is March 10, 2009.

Internal Market and Services Commissioner Charlie McCreevy said:

"We want to gather information on the practical application of the Investor Compensation Schemes Directive since it entered into force ten years ago, especially in light of the current financial crisis. This will help us to assess whether and how the Directive should be modified in order to better protect investors. I encourage all interested parties to give us their views."

This call for evidence is focused on the following issues:

  • the scope of the Directive in terms of services covered, also in the light of the implementation of Directive 2004/39/EC on markets in financial instruments (MiFID);
  • the amount of compensation;
  • the funding of the compensation schemes which represents a crucial part of the functioning of the mechanism;
  • some technical aspects which may hamper the efficient and timely functioning of the schemes (notably, any existing restrictions on the carrying of unpaid reimbursement debts over a certain period of time and the need to set an effective reasonable deadline for reimbursement).

Finally, the call for evidence considers issues related to the treatment of money market funds.

.

 

 






Write a comment